Quality of Women's Health Care
Indicators of the quality of health care can provide important information about the effectiveness, safety, timeliness, and patient-centeredness of women’s health services. Indicators used to monitor women’s health care in managed care plans include screening for chlamydia, screening for cervical cancer, and receipt of mammograms.
Despite a slight decline in chlamydia screenings for women aged 21–25 years enrolled in Medicaid from 2006 to 2007, females with Medicaid coverage were more likely to have received a chlamydia screening than those with private coverage (54.2 versus 39.2 percent, respectively). Since 2000, the percentage of sexually active females screened for chlamydia has increased by 89 percent among those in commercial plans and 43 percent among Medicaid participants.
In 2007, receipt of mammograms for women aged 40–69 years was approximately the same for women with private coverage and those covered through Medicare (69.1 and 67.3 percent, respectively). However, women enrolled in Medicaid were considerably less likely to have received a mammogram at least once during the previous 2 years (49.9 percent).
Cervical cancer screenings appear to be more accessible to women with commercial coverage than to those covered by Medicaid. Among women aged 21–64 years, cervical cancer screenings were received at least once during the previous 3 years by 81.7 percent of commercially-insured women and 64.7 percent of those covered by Medicaid.